141 related articles for article (PubMed ID: 28088076)
1. In vivo visualization of endogenous miR-21 using hyaluronic acid-coated graphene oxide for targeted cancer therapy.
Hwang DW; Kim HY; Li F; Park JY; Kim D; Park JH; Han HS; Byun JW; Lee YS; Jeong JM; Char K; Lee DS
Biomaterials; 2017 Mar; 121():144-154. PubMed ID: 28088076
[TBL] [Abstract][Full Text] [Related]
2. Hybrid graphene/Au activatable theranostic agent for multimodalities imaging guided enhanced photothermal therapy.
Gao S; Zhang L; Wang G; Yang K; Chen M; Tian R; Ma Q; Zhu L
Biomaterials; 2016 Feb; 79():36-45. PubMed ID: 26691399
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-Responsive Drug Release System for Selective Fluorescence Imaging and Photodynamic Therapy In Vivo.
Lee JS; Kim S; Na HK; Min DH
Adv Healthc Mater; 2016 Sep; 5(18):2386-95. PubMed ID: 27385533
[TBL] [Abstract][Full Text] [Related]
4. pH triggered in vivo photothermal therapy and fluorescence nanoplatform of cancer based on responsive polymer-indocyanine green integrated reduced graphene oxide.
Sharker SM; Lee JE; Kim SH; Jeong JH; In I; Lee H; Park SY
Biomaterials; 2015 Aug; 61():229-38. PubMed ID: 26005762
[TBL] [Abstract][Full Text] [Related]
5. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
[TBL] [Abstract][Full Text] [Related]
7. Degradable hyaluronic acid/protamine sulfate interpolyelectrolyte complexes as miRNA-delivery nanocapsules for triple-negative breast cancer therapy.
Wang S; Cao M; Deng X; Xiao X; Yin Z; Hu Q; Zhou Z; Zhang F; Zhang R; Wu Y; Sheng W; Zeng Y
Adv Healthc Mater; 2015 Jan; 4(2):281-90. PubMed ID: 25044638
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence Quenching Nanoprobes Dedicated to In Vivo Photoacoustic Imaging and High-Efficient Tumor Therapy in Deep-Seated Tissue.
Qin H; Zhou T; Yang S; Xing D
Small; 2015 Jun; 11(22):2675-86. PubMed ID: 25656695
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Targeting Anti-MicroRNA-155 Delivery Based on Biodegradable Poly(ester amine) and Hyaluronic Acid Shielding for Lung Cancer Therapy.
Yang Y; Jia Y; Xiao Y; Hao Y; Zhang L; Chen X; He J; Zhao Y; Qian Z
Chemphyschem; 2018 Aug; 19(16):2058-2069. PubMed ID: 29488305
[TBL] [Abstract][Full Text] [Related]
10. Photoresponsive fluorescent reduced graphene oxide by spiropyran conjugated hyaluronic acid for in vivo imaging and target delivery.
Nahain AA; Lee JE; Jeong JH; Park SY
Biomacromolecules; 2013 Nov; 14(11):4082-90. PubMed ID: 24106989
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
12. Graphene oxide/manganese ferrite nanohybrids for magnetic resonance imaging, photothermal therapy and drug delivery.
Yang Y; Shi H; Wang Y; Shi B; Guo L; Wu D; Yang S; Wu H
J Biomater Appl; 2016 Jan; 30(6):810-22. PubMed ID: 26296777
[TBL] [Abstract][Full Text] [Related]
13. A hyaluronic acid nanogel for photo-chemo theranostics of lung cancer with simultaneous light-responsive controlled release of doxorubicin.
Khatun Z; Nurunnabi M; Nafiujjaman M; Reeck GR; Khan HA; Cho KJ; Lee YK
Nanoscale; 2015 Jun; 7(24):10680-9. PubMed ID: 26030737
[TBL] [Abstract][Full Text] [Related]
14. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
15. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic/chemo therapy.
Chen WH; Luo GF; Qiu WX; Lei Q; Liu LH; Wang SB; Zhang XZ
Biomaterials; 2017 Feb; 117():54-65. PubMed ID: 27936417
[TBL] [Abstract][Full Text] [Related]
17. Reconsidering azobenzene as a component of small-molecule hypoxia-mediated cancer drugs: A theranostic case study.
Verwilst P; Han J; Lee J; Mun S; Kang HG; Kim JS
Biomaterials; 2017 Jan; 115():104-114. PubMed ID: 27886551
[TBL] [Abstract][Full Text] [Related]
18. Graphene Oxide Based Nanocarrier Combined with a pH-Sensitive Tracer: A Vehicle for Concurrent pH Sensing and pH-Responsive Oligonucleotide Delivery.
Hsieh CJ; Chen YC; Hsieh PY; Liu SR; Wu SP; Hsieh YZ; Hsu HY
ACS Appl Mater Interfaces; 2015 Jun; 7(21):11467-75. PubMed ID: 25945595
[TBL] [Abstract][Full Text] [Related]
19. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
Wu J; Zhou Y; Li S; Qu D; Zhu WH; Tian H
Biomaterials; 2017 Mar; 120():1-10. PubMed ID: 28011190
[TBL] [Abstract][Full Text] [Related]
20. Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy.
Jang E; Kim E; Son HY; Lim EK; Lee H; Choi Y; Park K; Han S; Suh JS; Huh YM; Haam S
Biomaterials; 2016 Oct; 105():12-24. PubMed ID: 27497057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
